$99.36
Value $8.4B
HQY and MSFT stock compared: price, dividend, valuation and results, from SEC filings.
$99.36
Value $8.4B
$505.89
Value $3.76T
HealthEquity (HQY) has a market value of $8.4B and Microsoft (MSFT) $3.76T. Over the last year, with dividends, HQY moved -0.7% and MSFT +0.5%. The P/E is 35.5 for HQY and 26.3 for MSFT. Dividend yield: HQY none, MSFT 0.72%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HQY$8.4B
MSFT$3.76T
MSFT is 448 times HQY
Revenue, 12 months
HQY$1.4B
MSFT$346B
MSFT is 254 times HQY
Net income, 12 months
HQY$236M
MSFT$143B
MSFT is 603 times HQY
Operating margin
HQY25.8%
MSFT47.1%
21.3 points apart
ROIC
HQY8.8%
MSFT28.7%
19.9 points apart
P/E
HQY35.5
MSFT26.3
HQY is 1.3 times MSFT
Dividend yield
HQY0.0%
MSFT0.7%
0.7 points apart
5-year return
HQY+52.3%
MSFT+55.2%
2.9 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HQY+52.3%
MSFT+55.2%
| Period | HQYWith dividends | MSFTWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | -0.7%Price -0.7% | +0.5%Price -0.3% |
| 3 years since November 17, 2023 | +47.7%+13.9% a yearPrice +47.7% | +39.7%+11.8% a yearPrice +36.8% |
| 5 years since November 17, 2021 | +52.3%+8.8% a yearPrice +52.3% | +55.2%+9.2% a yearPrice +49.2% |
| 10 years since November 18, 2016 | +141.5%+9.2% a yearPrice +141.5% | +837.8%+25.1% a yearPrice +738.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HQYHealthEquityMSFTMicrosoft
| Price | $99.36 | $505.89 |
|---|---|---|
| Market value | $8.4B | $3.76T |
| Enterprise value (EV) | $9.1B | $3.80T |
| P/E | 35.5 | 26.3 |
| P/E, 5-year median | – | 35.2 |
| P/B | 4.2 | 8.0 |
| EV/EBIT | 25.8 | 23.3 |
| Free cash flow yield | 5.8% | 1.6% |
| Revenue, 12 months | $1.4B | $346B |
|---|---|---|
| Net income, 12 months | $236M | $143B |
| Free cash flow, 12 months | $488M | $60.0B |
| Earnings per share, 12 months | $2.77 | $19.16 |
| Revenue growth, year on year | 9.5% | 17.8% |
| Revenue growth a year, past | +12.4%over 5 years | +14.6%over 5 years |
| EPS growth a year, past | +83.0%over 5 years | +17.4%over 5 years |
| Gross margin | 71.3% | 67.7% |
|---|---|---|
| Operating margin | 25.8% | 47.1% |
| Net margin | 17.4% | 41.2% |
| ROIC | 8.8% | 28.7% |
| ROE | 11.3% | 34.3% |
| Cash | $256M | $64.5B |
|---|---|---|
| Total debt | $971M | $134B |
| Net debt / EBITDA | 1.3 | 0.2 |
| Interest cover | 6.7× | 50.6× |
| Dividend yield | – | 0.7% |
|---|---|---|
| Dividend per share, 12 months | – | $3.64 |
| Dividend growth a year, past | – | +10.2%over 5 years |
| Buyback yield | 3.6% | 0.6% |
| Shareholder yield | 3.6% | 1.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Microsoft ($3.76T) is about 447.5 times HealthEquity ($8.4B), at today's prices.
Since November 18, 2016, HQY's price moved +141.5% and MSFT's +738.3%. With dividends: HQY +141.5% (+9.2% a year), MSFT +837.8% (+25.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for HealthEquity and 0.72% for Microsoft. Over the last twelve months they paid – and $3.64 per share.
At today's price, the P/E is 35.5 for HQY and 26.3 for MSFT. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 17.4% for HealthEquity and 41.2% for Microsoft, and the operating margin 25.8% and 47.1%. Revenue was $1.4B and $346B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.